HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing

NCT ID: NCT03138135

Last Updated: 2021-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

104 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-09

Study Completion Date

2018-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Home HIV self-testing has been FDA approved and allows users to read their own HIV test results at home, while home sexually transmitted infection (STI) test self-collection allows men to use a swab at home and mail it in for testing. The purpose of this study is to learn how Men who have Sex with Men (MSM) use these new testing options, a set of online support tools, and the option to test with someone to support them (a testing "buddy").

We will also evaluate whether the online tools help these men to connect with HIV prevention services such as Pre-Exposure Prophylaxis (PrEP) if they test HIV negative, and to HIV care services if they test HIV positive.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be randomized 2:1 after enrollment to the intervention and control condition. Data obtained from this study will be used to inform the further tailoring and distribution of an intervention for young Black and Latino MSM to increase utilization of home HIV self-testing and linkage to HIV treatment and Pre-Exposure Prophylaxis (PrEP).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Prevention Sexually Transmitted Diseases Pre-Exposure Prophylaxis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

The Intervention group will receive the HOME Study intervention.

Group Type EXPERIMENTAL

HOME Study intervention

Intervention Type BEHAVIORAL

Access to home HIV test kits, home STI self-collection kits, the HOME Study website, and the SexPro HIV risk assessment tool.

Control

The Control group will receive standard of care.

Group Type ACTIVE_COMPARATOR

Control

Intervention Type BEHAVIORAL

Counseling about the importance of quarterly HIV/STI testing and a PrEP information pamphlet.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HOME Study intervention

Access to home HIV test kits, home STI self-collection kits, the HOME Study website, and the SexPro HIV risk assessment tool.

Intervention Type BEHAVIORAL

Control

Counseling about the importance of quarterly HIV/STI testing and a PrEP information pamphlet.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Self-identify as Black or Latino.
* Report anal sex with at least one male sex partner in the prior 12 months.
* HIV negative by self-report.
* Currently own a cell phone.
* Willing and able to provide written informed consent.

Exclusion Criteria

* Inadequate contact information for follow-up.
* In a mutually monogamous sexual relationship for the past 12 months.
* Currently taking PrEP.
* Does not have reliable access to the Internet.
* Does not live, work, or play in the San Francisco Bay Area.
* Planning to move out of the Bay Area during the 9 month study period.
* Previously participated in the HOME Pilot study.
* Any medical, psychiatric, or social condition, or occupational, or other responsibility that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

Sponsor Role collaborator

San Francisco Department of Public Health

OTHER_GOV

Sponsor Role collaborator

University of California, San Francisco

OTHER

Sponsor Role collaborator

Public Health Foundation Enterprises, Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Susan Buchbinder

Director, Bridge HIV

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hyman Scott, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Public Health Foundation Enterprises; San Francisco Department of Public Health

Susan Buchbinder, MD

Role: PRINCIPAL_INVESTIGATOR

Public Health Foundation Enterprises; San Francisco Department of Public Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bridge HIV, San Francisco Department of Public Health

San Francisco, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://helpfighthiv.org

Bridge HIV Health Equity Studies homepage

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01AI104309

Identifier Type: NIH

Identifier Source: secondary_id

View Link

16-20492

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HIV Prevention Among At-risk Latinos in the Heartland
NCT04563715 ENROLLING_BY_INVITATION NA
Innovations in HIV Testing (TI)
NCT03271424 COMPLETED NA
Information Seeking About Pre-exposure Prophylaxis
NCT05728034 ACTIVE_NOT_RECRUITING NA
Pre-Exposure Prophylaxis in YMSM
NCT01033942 COMPLETED PHASE2